Treatment success rate for patients treated for MDR-TB in Europe (WHO region)
Europe (WHO region): Treatment success rate for patients treated for MDR-TB was 68.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in Europe (WHO region), 1999–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in Europe (WHO region) is 68.0%, measured in 2022.
Compared with earlier readings it is up 11.5% on the previous year and up 38.8% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Europe (WHO region) peaked at 78.0% in 2001 and was at its lowest, 41.0%, in 2004.
The long-run direction has been consistently rising across the 24 years of available data.
Treatment success rate for patients treated for MDR-TB in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 1999 | 50.0% | — |
| 2000 | 68.0% | +36.0% |
| 2001 | 78.0% | +14.7% |
| 2002 | 45.0% | -42.3% |
| 2003 | 43.0% | -4.4% |
| 2004 | 41.0% | -4.7% |
| 2005 | 66.0% | +61.0% |
| 2006 | 58.0% | -12.1% |
| 2007 | 53.0% | -8.6% |
| 2008 | 55.0% | +3.8% |
| 2009 | 48.0% | -12.7% |
| 2010 | 49.0% | +2.1% |
| 2011 | 46.0% | -6.1% |
| 2012 | 49.0% | +6.5% |
| 2013 | 51.0% | +4.1% |
| 2014 | 55.0% | +7.8% |
| 2015 | 57.0% | +3.6% |
| 2016 | 57.0% | +0.0% |
| 2017 | 59.0% | +3.5% |
| 2018 | 56.0% | -5.1% |
| 2019 | 59.0% | +5.4% |
| 2020 | 58.0% | -1.7% |
| 2021 | 61.0% | +5.2% |
| 2022 | 68.0% | +11.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 50.0% | 50.0% | 50.0% | 1 |
| 2000s | 55.5% | 41.0% | 78.0% | 10 |
| 2010s | 53.8% | 46.0% | 59.0% | 10 |
| 2020s | 62.3% | 58.0% | 68.0% | 3 |
More health data for Europe (WHO region)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Number of infant deaths, annual growth rate -5.46 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.27 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -8.58 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Europe (WHO region)?
- Treatment success rate for patients treated for mdr-tb in Europe (WHO region) was 68.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Europe (WHO region)?
- The highest recorded value was 78.0% in 2001.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Europe (WHO region)?
- The lowest recorded value was 41.0% in 2004.
- How does Europe (WHO region) rank for treatment success rate for patients treated for mdr-tb?
- Europe (WHO region) ranks 7th out of 11 groups with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Europe (WHO region)?
- Over the last ten years it is up 38.8%. The long-run trend across the full record is rising.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).